Get the Stockscreener App
178.95
2.42%
-4.44
Pre-market:
180.99
2.04
+1.14%
Icon Plc stock is traded at $178.95, with a volume of 1.22M.
It is down -2.42% in the last 24 hours and down -2.02% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$183.39
Open:
$177.995
24h Volume:
1.22M
Relative Volume:
1.29
Market Cap:
$14.46B
Revenue:
$8.31B
Net Income/Loss:
$747.89M
P/E Ratio:
19.95
EPS:
8.97
Net Cash Flow:
$1.23B
1W Performance:
-3.36%
1M Performance:
-2.02%
6M Performance:
-40.35%
1Y Performance:
-46.34%
1-Day Range:
$175.12
$181.61
1-Week Range:
$174.93
$188.01
52-Week Range:
$174.93
$347.72
Icon Plc Stock (ICLR) Company Profile
Compare ICLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
178.95 | 14.46B | 8.31B | 747.89M | 1.23B | 8.97 |
|
TMO
Thermo Fisher Scientific Inc
|
508.90 | 191.99B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
204.09 | 145.87B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
117.33 | 33.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
406.29 | 33.04B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
181.43 | 31.99B | 15.41B | 1.37B | 2.11B | 7.50 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
ROSEN, A LEADING LAW FIRM, Encourages ICON plc Investors to Secure Counsel Before Important ... - The Bakersfield Californian
ROSEN, A LEADING LAW FIRM, Encourages ICON plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICLR - GlobeNewswire Inc.
ICON plc (ICLR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ICON PLC at Barclays Healthcare Conference: Strategic Navigations - Investing.com
ICLR Shareholders Have Opportunity to Lead ICON PLC Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider
U.S. Contract Research Organization (CROs) Market Set to Witness Significant Growth by 2025-2032: IQVIA INC., - EIN News
ICON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH - GlobeNewswire
ICON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ICON plcICLR - TradingView
ICON plc Reports Strong Interim Financial Results for 2024-2025 - TipRanks
ICLR Investors Have Opportunity to Lead ICON PLC Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider
ICON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY - GlobeNewswire
ICON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ICON plc - GlobeNewswire Inc.
ICON Plc stock hits 52-week low at $179.01 amid market challenges - Investing.com
ICLR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Stockholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
ICON PLC (NASDAQ: ICLR) DEADLINE ALERT: Bernstein Liebhard - GlobeNewswire
ICLR ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against ICON Public Limited Company (ICLR) - The Malaysian Reserve
Deadline Alert: ICON plc (ICLR) Investors Who Lost Money - GlobeNewswire
ICLR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ICON plc Investors to Secure Counsel Before ... - The Bakersfield Californian
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ICON plc - GlobeNewswire
ICLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Clinical trials giant Icon Plc warns investors delay to its Covid vaccine study will hit its revenue for first half of 2025 - Irish Independent
ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fraud Lawsuit - PR Newswire
Apology: ICON plc, Dr Steve Cutler and Mr Brendan Brennan - The Irish Times
ICLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ICLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ICON plc - GlobeNewswire
ICLR Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against ICON Public Limited Company (ICLR) - The Malaysian Reserve
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ICON plc Investors to Secure Counsel Before - Bluefield Daily Telegraph
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ICON - StreetInsider.com
eClinical Solutions Market Key Players Analysis- Icon Plc, - openPR
ICON plc to Present at Upcoming Investor Conferences - BioSpace
ICON plc to Present at Major Healthcare Conferences - TipRanks
When and Where ICON's CEO Will Share Company Vision: Key March 2025 Investor Conferences Revealed - StockTitan
ICLR Class Action: Investors Must Act Before April 11 Deadline - Lawyer Monthly Magazine
Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials - Yahoo Finance
ICLR CLASS ACTION: Lose Money on ICON plc? Investors are - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ICON plc - GlobeNewswire
ICLR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
ICON Public Limited Company Class Action: Levi & Korsinsky Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025ICLR - ACCESS Newswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ICON plc Investors to Secure Counsel Before - The Bakersfield Californian
Deadline Alert: ICON plc (ICLR) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About - EIN News
ICON Plc stock hits 52-week low at $179.5 amid market challenges - Investing.com
ICON plc Announces Delay in COVID Vaccine Study - TipRanks
ICLR REMINDER: ICON plc was Sued for Securities Fraud; - GlobeNewswire
ICLR Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against ICON Public Limited Company (ICLR) - The Malaysian Reserve
Robbins LLP Reminds ICON PLC (ICLR) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses - Finansavisen
ICLR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - Finansavisen
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ICON plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICLR - TradingView
ICLR STOCK ALERT: A Class Action has been filed on behalf - GlobeNewswire
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):